Clinical Trial Update: Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of intranasal fentanyl for breakthrough cancer pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Fentanyl (intranasal) (Fentanyl)

Snippet

Sponsor: Nycomed | Conditions: Cancer | Phase 3 | Status: COMPLETED